Floatz logo

HUMAN ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX

Von Willebrand Disease (VWD)

Assiut Universityprotein_peptideActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Von Willebrand Disease (VWD) cohort.

Asset / SponsorPhaseRating
Alphanate Sd/Ht
Grifols Biologicals, LLC
Phase 4BB
FACTOR VIII (HUMAN)
Bio Products Laboratory
Phase 3BB
INTERLEUKIN-11
University of Pittsburgh
Phase 2B
Oprelvekin
University of Pittsburgh
Phase 2CCC
Von Willebrand Factor
National Center for Research Resources (NCRR)
Phase 1CC
Tranexamic Acid
Assiut University
D
Rondaptivon pegol sodium
Medical University of Vienna
Phase 2NR
Cyclokapron
Mary M. Gooley Hemophilia Center
N/ANR

Same molecule, other indications

HUMAN ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX is also rated in:

severe hemophilia ADormant
BBB
Indicative ·
75 / 100
View asset →
inherited blood coagulation disorderDormant
BB
Indicative ·
69 / 100
View asset →
hemophilia BDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →